Erratum: ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma (PLOS ONE (2012) 7:6 (e38842) DOI: 10.1371/journal.pone.0038842);ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Qi, Songtao ^a   Song, Ye ^a   Peng, Yuping ^a   Wang, Hao ^a   Long, Hao ^a   Yu, Xiaoli ^a   Li, Zhiyong ^a   Fang, Luxiong ^a   Wu, Aibing ^a   Luo, Weiren ^a   Zhen, Yan ^a   Zhou, Ying ^a   Chen, Yan ^a   Mai, Chunping ^a   Liu, Zhen ^a,b   Fang, Weiyi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASPASE 3; CASPASE 6; CASPASE 9; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P15; PROTEIN P21; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZINC FINGER E BOX BINDING HOMEOBOX 2 PROTEIN; ZINC FINGER PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CANCER GRADING; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 84862744838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0231386     Document Type: Erratum

References (39)

1. Ohgaki H, Kleihues P, (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170: 1445-1453.
2. Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, et al. (2006) Changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist 11: 165-180.
3. Reifenberger G, Hentschel B, Felsberg J, Schackert G, Simon M, et al. (2011) Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. Int J Cancer.
4. Jansen M, Yip S, Louis DN, (2010) Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. Lancet Neurol 9: 717-726.
5. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, et al. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710.
6. Zhuang W, Qin Z, Liang Z, (2009) The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim Biophys Sin (Shanghai) 41: 341-351.
7. Huang J, Gao J, Lv X, Li G, Hao D, et al. (2010) Target gene therapy of glioma: overexpression of BAX gene under the control of both tissue-specific promoter and hypoxia-inducible element. Acta Biochim Biophys Sin (Shanghai) 42: 274-280.
8. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, et al. (2002) Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 161: 1881-1891.
9. Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, et al. (2005) Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103: 1631-1643.
10. Imamichi Y, Konig A, Gress T, Menke A, (2007) Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer. Oncogene 26: 2381-2385.
11. Park SM, Gaur AB, Lengyel E, Peter ME, (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907.
12. Brabletz S, Brabletz T, (2010) The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep 11: 670-677.
13. Wiklund ED, Bramsen JB, Hulf T, Dyrskjot L, Ramanathan R, et al. (2011) Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer 128: 1327-1334.
14. Mejlvang J, Kriajevska M, Vandewalle C, Chernova T, Sayan AE, et al. (2007) Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell 18: 4615-4624.
15. Xia M, Hu M, Wang J, Xu Y, Chen X, et al. (2010) Identification of the role of Smad interacting protein 1 (SIP1) in glioma. J Neurooncol 97: 225-232.
16. Shin S, Blenis J, (2010) ERK2/Fra1/ZEB pathway induces epithelial-to-mesenchymal transition. Cell Cycle 9: 2483-2484.
17. Savagner P, (2001) Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23: 912-923.
18. Andersen H, Mejlvang J, Mahmood S, Gromova I, Gromov P, et al. (2005) Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol Cell Biol 25: 9138-9150.
19. Davis JN, Wojno KJ, Daignault S, Hofer MD, Kuefer R, et al. (2006) Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer. Cancer Res 66: 11897-11906.
20. Yang G, Zhang R, Chen X, Mu Y, Ai J, et al. (2011) MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med (Berl) 89: 1037-1050.
21. Matsumura I, Tanaka H, Kanakura Y, (2003) E2F1 and c-Myc in cell growth and death. Cell Cycle 2: 333-338.
22. Wang J, Wang H, Li Z, Wu Q, Lathia JD, et al. (2008) c-Myc is required for maintenance of glioma cancer stem cells. PLoS One 3: e3769.
23. Panicker SP, Raychaudhuri B, Sharma P, Tipps R, Mazumdar T, et al. (2010) p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation. Oncotarget 1: 289-303.
24. Stanic G, Cupic H, Zarkovic K, Tomas D, Kruslin B, (2011) C-myc expression in the microvessels of medulloblastoma. Coll Antropol 35: 39-42.
25. Zhou YX, Huang YL, Xu QN, Ye M, Sun CF, et al. (2002) [Several monomes from Tripterygium wilfordii inhibit proliferation of glioma cells in vitro]. Ai Zheng 21: 1106-1108.
26. Fogh J, Wright WC, Loveless JD, (1977) Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 58: 209-214.
27. Sayan AE, Griffiths TR, Pal R, Browne GJ, Ruddick A, et al. (2009) SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci U S A 106: 14884-14889.
28. Browne G, Sayan AE, Tulchinsky E, (2010) ZEB proteins link cell motility with cell cycle control and cell survival in cancer. Cell Cycle 9: 886-891.
29. Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, et al. (2011) MicroRNA-708 Induces Apoptosis and Suppresses Tumorigenicity in Renal Cancer Cells. Cancer Res 71: 6208-6219.
30. Smulson ME, Simbulan-Rosenthal CM, Boulares AH, Yakovlev A, Stoica B, et al. (2000) Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1. Adv Enzyme Regul 40: 183-215.
31. Ponnala S, Veeravalli KK, Chetty C, Dinh DH, Rao JS, (2011) Regulation of DNA repair mechanism in human glioma xenograft cells both in vitro and in vivo in nude mice. PLoS One 6: e26191.
32. Stilmann M, Hinz M, Arslan SC, Zimmer A, Schreiber V, et al. (2009) A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation. Mol Cell 36: 365-378.
33. Hunter JE, Willmore E, Irving JA, Hostomsky Z, Veuger SJ, et al. (2011) NF-kappaB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene.
34. Zanotto-Filho A, Braganhol E, Schroder R, de Souza LH, Dalmolin RJ, et al. (2011) NFkappaB inhibitors induce cell death in glioblastomas. Biochem Pharmacol 81: 412-424.
35. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, et al. (2007) NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26: 711-724.
36. Derynck R, Zhang YE, (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584.
37. Postigo AA, Depp JL, Taylor JJ, Kroll KL, (2003) Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J 22: 2453-2462.
38. Wu A, Wu B, Guo J, Luo W, Wu D, et al. (2011) Elevated expression of CDK4 in lung cancer. J Transl Med 9: 38.
39. Liu Z, Li X, He X, Jiang Q, Xie S, et al. (2011) Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism. Int J Cancer 128: 2562-2571.